NCT05384366View on ClinicalTrials.gov

Neoadjuvant Chemotherapy in Cervical Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
Cervix CancerCervical CancerCancer of the Uterine Cervix
Interventions
DRUG

Neoadjuvant chemotherapy

doublet of taxane and carboplatin

Trial Locations (1)

221005

Banaras Hindu University, Varanasi

All Listed Sponsors
lead

Banaras Hindu University

OTHER

NCT05384366 - Neoadjuvant Chemotherapy in Cervical Cancer | Biotech Hunter | Biotech Hunter